Showing results (571-580 of 669) with videos related to
Sort By:
Pageof 67
Hemasphere|September 9, 2022
What Are the Attributes Prioritized in the Choice of Therapy in Chronic Lymphocytic Leukemia? A Patient-physician Cross-matching Analysis of a Discrete Choice ExperimentLuca Laurenti, Gianluca Gaidano, Francesca Romana Mauro, et al.Hemasphere|August 24, 2022
Precision Medicine and Sickle Cell DiseaseSara El Hoss, Wassim El Nemer, David C ReesHemasphere|May 10, 2021
Patient-reported Effects of Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2, on Myelofibrosis-related Symptoms and Health-related Quality of Life in the Randomized, Placebo-controlled, Phase III JAKARTA TrialRuben A Mesa, Nicolaas Schaap, Alessandro M Vannucchi, et al.Hemasphere|June 7, 2021
Functional Consequences of Mutations in Myeloproliferative NeoplasmsStefan N Constantinescu, William Vainchenker, Gabriel Levy, et al.Hemasphere|January 6, 2021
Challenges and Perspectives for Therapeutic Targeting of Myeloproliferative NeoplasmsSime Brkic, Sara C MeyerHemasphere|July 8, 2021
COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell LymphomaErik Gaitzsch, Verena Passerini, Elham Khatamzas, et al.Hemasphere|July 8, 2021
The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell DiseaseJulio Delgado, Caroline Voltz, Milena Stain, et al.Hemasphere|June 16, 2021
Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative NeoplasmsLise Secardin, Cintia Gomez Limia, Suzana da Silva-Benedito, et al.Hemasphere|June 17, 2021
Novel Peptide-drug Conjugate Melflufen Efficiently Eradicates Bortezomib-resistant Multiple Myeloma Cells Including Tumor-initiating Myeloma Progenitor CellsKonstantin Byrgazov, Andrej Besse, Marianne Kraus, et al.Pageof 67